259 related articles for article (PubMed ID: 26296472)
1. Mutations of desmoglein-2 in sudden death from arrhythmogenic right ventricular cardiomyopathy and sudden unexplained death.
Zhang M; Xue A; Shen Y; Oliveira JB; Li L; Zhao Z; Burke A
Forensic Sci Int; 2015 Oct; 255():85-8. PubMed ID: 26296472
[TBL] [Abstract][Full Text] [Related]
2. PKP2 mutations in sudden death from arrhythmogenic right ventricular cardiomyopathy (ARVC) and sudden unexpected death with negative autopsy (SUDNA).
Zhang M; Tavora F; Oliveira JB; Li L; Franco M; Fowler D; Zhao Z; Burke A
Circ J; 2012; 76(1):189-94. PubMed ID: 22019812
[TBL] [Abstract][Full Text] [Related]
3. Sudden death during exercise in a juvenile with arrhythmogenic right ventricular cardiomyopathy and desmoglein-2 gene substitution: a case report.
Sato T; Nishio H; Suzuki K
Leg Med (Tokyo); 2011 Nov; 13(6):298-300. PubMed ID: 22000064
[TBL] [Abstract][Full Text] [Related]
4. Identification of arrhythmogenic right ventricular cardiomyopathy-causing gene mutations in young sudden unexpected death autopsy cases.
Sato T; Nishio H; Suzuki K
J Forensic Sci; 2015 Mar; 60(2):457-61. PubMed ID: 25693453
[TBL] [Abstract][Full Text] [Related]
5. Mutated desmoglein-2 proteins are incorporated into desmosomes and exhibit dominant-negative effects in arrhythmogenic right ventricular cardiomyopathy.
Rasmussen TB; Palmfeldt J; Nissen PH; Magnoni R; Dalager S; Jensen UB; Kim WY; Heickendorff L; Mølgaard H; Jensen HK; Baandrup UT; Bross P; Mogensen J
Hum Mutat; 2013 May; 34(5):697-705. PubMed ID: 23381804
[TBL] [Abstract][Full Text] [Related]
6. Case report of familial sudden cardiac death caused by a DSG2 p.F531C mutation as genetic background when carrying with heterozygous KCNE5 p.D92E/E93X mutation.
Lin Y; Huang J; He S; Feng R; Zhong Z; Liu Y; Ye W; Li X; Liao H; Fei H; Rao F; Shan Z; Deng C; Zhan X; Xue Y; Liu H; Zhang B; Wang K; Zhang Q; Wu S; Lin X
BMC Med Genet; 2018 Aug; 19(1):148. PubMed ID: 30129429
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
[TBL] [Abstract][Full Text] [Related]
8. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Hermida A; Fressart V; Hidden-Lucet F; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Mansencal N; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller DI; Rouanet S; Charron P; Gandjbakhch E
Eur J Heart Fail; 2019 Jun; 21(6):792-800. PubMed ID: 30790397
[TBL] [Abstract][Full Text] [Related]
9. In vitro analysis of arrhythmogenic cardiomyopathy associated desmoglein-2 (DSG2) mutations reveals diverse glycosylation patterns.
Debus JD; Milting H; Brodehl A; Kassner A; Anselmetti D; Gummert J; Gaertner-Rommel A
J Mol Cell Cardiol; 2019 Apr; 129():303-313. PubMed ID: 30885746
[TBL] [Abstract][Full Text] [Related]
10. Case reports of two pedigrees with recessive arrhythmogenic right ventricular cardiomyopathy associated with homozygous Thr335Ala variant in DSG2.
Qadri S; Anttonen O; Viikilä J; Seppälä EH; Myllykangas S; Alastalo TP; Holmström M; Heliö T; Koskenvuo JW
BMC Med Genet; 2017 Aug; 18(1):86. PubMed ID: 28818065
[TBL] [Abstract][Full Text] [Related]
11. Desmoglein-2 mutations in arrhythmogenic right ventricular cardiomyopathy: a genotype-phenotype characterization of familial disease.
Syrris P; Ward D; Asimaki A; Evans A; Sen-Chowdhry S; Hughes SE; McKenna WJ
Eur Heart J; 2007 Mar; 28(5):581-8. PubMed ID: 17105751
[TBL] [Abstract][Full Text] [Related]
12. Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy.
Rigato I; Bauce B; Rampazzo A; Zorzi A; Pilichou K; Mazzotti E; Migliore F; Marra MP; Lorenzon A; De Bortoli M; Calore M; Nava A; Daliento L; Gregori D; Iliceto S; Thiene G; Basso C; Corrado D
Circ Cardiovasc Genet; 2013 Dec; 6(6):533-42. PubMed ID: 24070718
[TBL] [Abstract][Full Text] [Related]
13. An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis.
Chatterjee D; Fatah M; Akdis D; Spears DA; Koopmann TT; Mittal K; Rafiq MA; Cattanach BM; Zhao Q; Healey JS; Ackerman MJ; Bos JM; Sun Y; Maynes JT; Brunckhorst C; Medeiros-Domingo A; Duru F; Saguner AM; Hamilton RM
Eur Heart J; 2018 Nov; 39(44):3932-3944. PubMed ID: 30239670
[TBL] [Abstract][Full Text] [Related]
14. Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice.
Fressart V; Duthoit G; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Dubourg O; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller D; Hidden-Lucet F; Simon F; Bessirard V; Roux-Buisson N; Hebert JL; Azarine A; Casset-Senon D; Rouzet F; Lecarpentier Y; Fontaine G; Coirault C; Frank R; Hainque B; Charron P
Europace; 2010 Jun; 12(6):861-8. PubMed ID: 20400443
[TBL] [Abstract][Full Text] [Related]
15. Desmoglein-2 mutations in propeptide cleavage-site causes arrhythmogenic right ventricular cardiomyopathy/dysplasia by impairing extracellular 1-dependent desmosomal interactions upon cellular stress.
Vite A; Gandjbakhch E; Hery T; Fressart V; Gary F; Simon F; Varnous S; Hidden Lucet F; Charron P; Villard E
Europace; 2020 Feb; 22(2):320-329. PubMed ID: 31845994
[TBL] [Abstract][Full Text] [Related]
16. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy.
Pilichou K; Nava A; Basso C; Beffagna G; Bauce B; Lorenzon A; Frigo G; Vettori A; Valente M; Towbin J; Thiene G; Danieli GA; Rampazzo A
Circulation; 2006 Mar; 113(9):1171-9. PubMed ID: 16505173
[TBL] [Abstract][Full Text] [Related]
17. Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: results from a multicenter study.
Bhuiyan ZA; Jongbloed JD; van der Smagt J; Lombardi PM; Wiesfeld AC; Nelen M; Schouten M; Jongbloed R; Cox MG; van Wolferen M; Rodriguez LM; van Gelder IC; Bikker H; Suurmeijer AJ; van den Berg MP; Mannens MM; Hauer RN; Wilde AA; van Tintelen JP
Circ Cardiovasc Genet; 2009 Oct; 2(5):418-27. PubMed ID: 20031616
[TBL] [Abstract][Full Text] [Related]
18. Rare non-coding Desmoglein-2 variant contributes to Arrhythmogenic right ventricular cardiomyopathy.
Christensen AH; Andersen CB; Wassilew K; Svendsen JH; Bundgaard H; Brand SM; Schmitz B
J Mol Cell Cardiol; 2019 Jun; 131():164-170. PubMed ID: 31051180
[TBL] [Abstract][Full Text] [Related]
19. Distal myopathy induced arrhythmogenic right ventricular cardiomyopathy in a pedigree carrying novel DSG2 null variant.
Chen P; Li Z; Yu B; Ma F; Li X; Wang DW
Int J Cardiol; 2020 Jan; 298():25-31. PubMed ID: 31653443
[TBL] [Abstract][Full Text] [Related]
20. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers.
Bhonsale A; Groeneweg JA; James CA; Dooijes D; Tichnell C; Jongbloed JD; Murray B; te Riele AS; van den Berg MP; Bikker H; Atsma DE; de Groot NM; Houweling AC; van der Heijden JF; Russell SD; Doevendans PA; van Veen TA; Tandri H; Wilde AA; Judge DP; van Tintelen JP; Calkins H; Hauer RN
Eur Heart J; 2015 Apr; 36(14):847-55. PubMed ID: 25616645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
